Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 2.36Cr 2.12Cr 1.94Cr 1.77Cr 3.33Cr 222.08Cr 3.44Cr 23Cr 9.31Cr 118.5Cr 8.87Cr 8.68Cr 374.08Cr P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 4.22Cr 3.78Cr 3.46Cr 3.16Cr 5.95Cr 396.55Cr 6.13Cr 42Cr 17Cr 211.59Cr 16Cr 15Cr 667.97Cr EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/17/05 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/17/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/17/14 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/16/14 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/16/05 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/16/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/16/08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/16/01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/15/10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/15/04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/15/02 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 month+4.55%
3 months-34.29%
6 months-55.77%
Current year-30.30%
1 week 0
Extreme 0.0023
0
1 month 0
Extreme 0.0023
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-69.33%+43.75% 9L
-1.74%+1.20%-37.64%-57.11% 159.01Cr
-3.82%-6.46% - - 139.27Cr
+0.12%+3.21%-33.84%+37.79% 117.95Cr
+1.85%-12.39%-29.69%+112.82% 108.48Cr
+1.19%+6.37%+33.49%+46.44% 97Cr
+5.15%+6.49%+159.23%+622.07% 88Cr
-2.79%+4.09%+33.05%-28.69% 58Cr
-1.89%-0.32%-38.38%+12.66% 56Cr
+1.60%-15.62%-2.02%+83.68% 56Cr
Average -0.17%-3.49%+1.65%+97.05% 87.99Cr
Weighted average by Cap. -0.35%-2.83%+5.00%+95.02%

Financials

2015 2016
Net sales 2.55Cr 2.29Cr 2.09Cr 1.91Cr 3.59Cr 239.53Cr 3.71Cr 25Cr 10Cr 127.81Cr 9.56Cr 9.36Cr 403.48Cr 3.23Cr 2.9Cr 2.65Cr 2.42Cr 4.56Cr 303.9Cr 4.7Cr 32Cr 13Cr 162.16Cr 12Cr 12Cr 511.92Cr
Net income 54.95L 49.28L 45.04L 41.11L 77.46L 52Cr 79.9L 5.43Cr 2.16Cr 28Cr 2.06Cr 2.02Cr 87Cr 20.61L 18.49L 16.9L 15.42L 29.06L 19Cr 29.97L 2.04Cr 81.21L 10Cr 77.37L 75.71L 33Cr
Net Debt 2.48Cr 2.22Cr 2.03Cr 1.86Cr 3.5Cr 233.17Cr 3.61Cr 25Cr 9.77Cr 124.41Cr 9.31Cr 9.11Cr 392.76Cr 1.86Cr 1.66Cr 1.52Cr 1.39Cr 2.62Cr 174.47Cr 2.7Cr 18Cr 7.31Cr 93Cr 6.97Cr 6.82Cr 293.88Cr
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock